Contributions to Nephrology 2003
DOI: 10.1159/000071390
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Infections in Peritoneal Dialysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 8 publications
0
4
0
Order By: Relevance
“…1,[2][3][4] In this study, we investigated the association of time of hospital admission, initial (present at the time of hospital admission) peritoneal neutrophil and lymphomononuclear cell profiles, clinical and laboratory parameters with the course of peritonitis, and the length of hospital stay because of peritonitis in PD patients.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…1,[2][3][4] In this study, we investigated the association of time of hospital admission, initial (present at the time of hospital admission) peritoneal neutrophil and lymphomononuclear cell profiles, clinical and laboratory parameters with the course of peritonitis, and the length of hospital stay because of peritonitis in PD patients.…”
Section: Discussionmentioning
confidence: 99%
“…[17][18][19] The incidence of culture-negative peritonitis, which may happen for a variety of technical or clinical reasons, in series ranges from 13.7 to 21%. 4,17 The incidence of culture-negative peritonitis is high in peritonitis attacks because of low virulence microorganisms or coagulase-negative staphylococci and may rise up to 20% in some series. 1,11 In our study, the incidence of culture-negative peritonitis was 28.7%, which was relatively higher than reported in the literature.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Peritoneal dialysis (PD) represents an important therapeutic approach to chronic kidney disease (CKD), and its integration with other techniques ensures the optimization of the entire renal replacement therapy program [1]. Since Wilhelm Kolf in the early 1960s first reported the successful PD of a patient with CKD, this technique has continued to evolve, focusing on reduction of exit-site infection and peritonitis rates, optimal dialysis prescription, biocompatibility issues, catheters, and insertion technique [2].…”
Section: Introductionmentioning
confidence: 99%